Association between diabetes, diabetes treatment and risk of developing endometrial cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between diabetes, diabetes treatment and risk of developing endometrial cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 7, Pages 1432-1439
Publisher
Springer Nature
Online
2014-07-23
DOI
10.1038/bjc.2014.407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin and the risk of endometrial cancer: A case–control analysis
- (2013) Claudia Becker et al. GYNECOLOGIC ONCOLOGY
- The Role of Preexisting Diabetes Mellitus on Incidence and Mortality of Endometrial Cancer
- (2013) Zhi-Hua Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Insulin resistance: A significant risk factor of endometrial cancer
- (2012) Nan Mu et al. GYNECOLOGIC ONCOLOGY
- Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies
- (2012) Jody M. Jackson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Metformin Reverses Progestin Resistance in Endometrial Cancer Cells by Downregulating GloI Expression
- (2011) Zhenbo Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis
- (2010) E. J. Crosbie et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin Treatment Exerts Antiinvasive and Antimetastatic Effects in Human Endometrial Carcinoma Cells
- (2010) Bee K. Tan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells
- (2010) Ya Xie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship
- (2009) Amanda Nickles Fader et al. GYNECOLOGIC ONCOLOGY
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
- (2009) Leigh A. Cantrell et al. GYNECOLOGIC ONCOLOGY
- A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer
- (2008) M. J. Gunter et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements
- (2008) Karen L Margolis et al. Clinical Trials
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- LKB1 and AMPK in cell polarity and division
- (2008) Tyisha Williams et al. TRENDS IN CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started